Aleksi Tornio

SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid

Aleksi Tornio, Juha Vakkilainen, Mikko Neuvonen et al. · Pharmacogenetics and Genomics · 2015 · 408 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions

Aleksi Tornio, Anne M. Filppula, O Kailari et al. · Clinical Pharmacology & Therapeutics · 2014 · 141 citations

Medicine, Pharmacokinetics, Pharmacology +17

Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone

Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen et al. · Drug Metabolism and Disposition · 2007 · 114 citations

Medicine, Pharmacokinetics, Pharmacology +8

The Effect of Gemfibrozil on Repaglinide Pharmacokinetics Persists for at Least 12 h After the Dose: Evidence for Mechanism-based Inhibition of CYP2C8 In Vivo

Aleksi Tornio, Mikko Niemi, Mikko Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2008 · 90 citations

Medicine, Pharmacokinetics, Pharmacology +14

Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide

Mikko Niemi, Aleksi Tornio, Marja K. Pasanen et al. · European Journal of Clinical Pharmacology · 2006 · 86 citations

Pharmacy, Pharmacokinetics, Pharmacology +6